Lauer Wealth LLC Trims Stock Position in CVS Health Co. (NYSE:CVS)

Lauer Wealth LLC lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 26.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 6,003 shares of the pharmacy operator’s stock after selling 2,116 shares during the quarter. CVS Health makes up about 0.3% of Lauer Wealth LLC’s investment portfolio, making the stock its 25th biggest position. Lauer Wealth LLC’s holdings in CVS Health were worth $377,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health during the third quarter worth about $31,000. Crewe Advisors LLC bought a new stake in shares of CVS Health during the 1st quarter worth about $40,000. Retirement Group LLC boosted its position in shares of CVS Health by 54.3% during the 1st quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock valued at $41,000 after purchasing an additional 182 shares in the last quarter. Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health in the 3rd quarter valued at approximately $33,000. Finally, First Community Trust NA raised its stake in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CVS. Evercore ISI raised their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Truist Financial boosted their price objective on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research note on Friday, October 11th. Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Wells Fargo & Company boosted their price objective on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Finally, Barclays dropped their price objective on shares of CVS Health from $82.00 to $75.00 and set an “overweight” rating on the stock in a report on Wednesday, October 23rd. Nine investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $74.58.

CVS Health Stock Up 1.5 %

NYSE:CVS traded up $0.87 during trading hours on Monday, reaching $57.36. 1,893,336 shares of the company traded hands, compared to its average volume of 11,179,563. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The business’s 50-day moving average price is $59.82 and its two-hundred day moving average price is $59.84. The stock has a market capitalization of $72.01 billion, a P/E ratio of 9.93, a P/E/G ratio of 0.84 and a beta of 0.54.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.21 earnings per share. Analysts predict that CVS Health Co. will post 6.41 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.64%. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.